Urocortin induces endothelium-dependent vasodilatation and hyperpolarization of rat mesenteric arteries by activating Ca2+-activated K+ channels

Tohoku Journal of Experimental Medicine

Volumn 213, Issue 1, 2007, Pages 89-98

  Seçilmiş, M Ata ^a   Özü, Özlem Yorulmaz ^a   Emre, Mustafa ^a   Büyükafsar, Kansu ^b   Kiroǧlu, Olcay Ergürhan ^a   Ertuǧ, Peyman ^a   Karataş, Yusuf ^a   Önder, Serpil ^a   Şingirik, Ergin ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

^b MERSIN UNIVERSITY   (Turkey)

Author keywords

Ca2+ activated K+ channels; Charybdotoxin; Hyperpolarization; Mesenteric artery; Urocortin

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; APAMIN; CALCIUM ACTIVATED POTASSIUM CHANNEL; CHARYBDOTOXIN; GLIBENCLAMIDE; GUANYLATE CYCLASE INHIBITOR; INDOMETACIN; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE; POTASSIUM CHANNEL BLOCKING AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; SAPONIN; UROCORTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTERY PERFUSION; ARTICLE; CALCIUM CONDUCTANCE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME INHIBITION; EXTRACELLULAR SPACE; HUMAN; HYPERPOLARIZATION; MALE; MESENTERY BLOOD VESSEL; NONHUMAN; PERFUSION PRESSURE; PROTEIN FUNCTION; RAT; SUPERIOR MESENTERIC ARTERY; VASODILATATION;

ACETYLCHOLINE; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; ELECTROPHYSIOLOGY; ENDOTHELIUM, VASCULAR; MALE; MESENTERIC ARTERY, SUPERIOR; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; RATS; RATS, WISTAR; VASODILATION;

EID: 34948854859     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.213.89     Document Type: Article

References (40)

1. +]: A functional approach to separating EDHF- and EDNO-related mechanisms in perfused rat mesenteric arterial bed. J. Cardiovasc. Pharmacol., 21, 423-429.
2. Chan, Y.C., Yao, X.Q., Lau, C.W., Chan, F.L., He, G.W., Bourreau, J.P. & Huang, Y. (2004) The relaxant effect of urocortin in rat pulmonary arteries. Regul. Pept., 121, 11-18.
3. Chen, G., Suzuki, H. & Weston, A.H. (1988) Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br. J. Pharmacol., 95, 1165-1174.
4. Chen, Z.W., Huang, Y., Yang, Q., Li, X., Wei, W. & He, G.W. (2005) Urocortin-induced relaxation in the human internal mammary artery. Cardiovasc. Res., 65, 913-920.
5. De Souza, E.B. (1995) Corticotropin-releasing factor receptors: Phsiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology, 20, 789-819.
6. Donaldson, C.J., Sutton, S.W., Perrin, M.H., Corrigan, A.Z., Lewis, K.A., Rivier, J.E., Vaughan, J.M. & Vale, W.W. (1996) Cloning and characterization of human urocortin. Endocrinology, 137, 2167-2170.
7. Dunn, A.J. & Berridge, C.W. (1990) Phsiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety of stres responses? Brain Res. Rev., 15, 71-100.
8. Fisher, L.A., lessen, G. & Brown, M.R. (1983) Corticotropin-releasing factor (CRF): Mechanism to elevate arterial pressure and heart rate. Regul. Pept., 5, 153-161.
9. Gardiner, S.M., March, J.E., Kemp, P.A., Davenport, A.P., Wiley, K.E. & Bennett, T. (2005) Regional haemodynamic actions of selective corticotropin-releasing factor type 2 receptor ligands in conccious rats. J. Pharmacol. Exp. Ther., 312, 53-60.
10. Garland, J.C. & McPherson, G.A. (1992) Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery. Br. J. Pharmacol., 105, 429-435.
11. Heldwein, K.A., Redick, D.L., Rittenberg, M.B., Claycomb, W.C. & Stenzel-Poore, M.R (1096) Corticotropin-releasing hormone receptor expression and functional coupling in neonatal cardiac myocytes and AT-1 cells. Endocrinology, 137, 301-3639.
12. Herbert, J. (1993) Peptides in the limbic system neurochemical codes for co-ordinated adaptive responses to behaviouoral and phsiological demand. Prog. Neurobiol., 41, 723-791.
13. Hillhouse, E.W., Randeva, H., Ladds, G. & Grammatopoulos, D. (2002) Corticotropin-releasing hormone receptors. Biochem. Soc. Trans., 30, 428-432.
14. + channels. Br. J. Pharmacol., 135, 1467-1476.
15. + channels in endothelium-independent relaxation by urocortin in the rat coronary artery. Cardiovasc. Res., 57, 824-833.
16. Hwa, J.J., Ghibaudi, L., Williams, R & Chatterjee, M. (1994) Comparison of acetylcholine-dependent relaxation in large and small arteries of rat mesenteric vascular bed. Am. J. Physiol., 266, H952-H958.
17. Jain, V., Vedernikov, Y.P., Sade, G.R., Chwalisz, K. & Darfield, R.E. (1999) Endothelium-dependent and -independent mechanism of vasorelaxation by corticotropin-releasing factor in pregnant rat uterine artery. J. Pharmacol. Exp. Ther., 288, 407-413.
18. 2+] in human epidermoid A-431 cells. Eur. J. Pharmacol., 329, 237-244.
19. Lei, S., Richter, R., Bienert, M. & Mulvany, M.J. (1993) Relaxing actions of corticotropin-releasing factor on rat resistance arteries. Br. J. Pharmacol., 108, 941-947.
20. Leitch, I.M., Boura, ALA., Botti, C., Read, M.A., Walters, W.A.W. & Smith, R. (1998) Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro. J. Clin. Endocrinol. Metab., 83, 4510-4513.
21. Lubomirov, L., Gagov, H., Petkova-Kirova, P., Duridanova, D., Kalentchuk, V.U. & Schubert, R. (2001) Urocortin relaxes rat tail arteries by a PKA-mediated reduction of the sensitivity of the contractile apparatus for calcium. Br. J. Pharmacol., 134, 1564-1570.
22. MacCannell, K.L., Lederis, K., Hamilton, P.L. & Rivier, J. (1982) Amunine (ovine CRF), urotensin I and sauvagine, three structurally related peptides, produce selective dilation of the mesenteric circulation. Pharmacology, 25, 116-120.
23. MacCannell, K.L., Hamilton, P.L., Lederis, K., Newton, C.A. & Rivier, J. (1984) Corticotropin releasing factor-like peptides produce selective dilatation of the dog mesenteric circulation. Gastroenterology, 87, 94-102.
24. MacCannell, K.L., Newton, C.A., Lederis, K., Rivier, J. & Tiffany, M. (1986) Use of selective mesenteric vasodilator peptides in experimental nonocclusive mesenteric ischemia in the dog. Gastroenterology, 90, 669-676.
25. Moncada, S., Rees, D.D., Schulz, R. & Palmer, R.M.J. (1991) Development and mechanism of a specific supersensitivity to nitrovasodilators following inhibition of vascular nitric oxide synthesis in vivo. Proc. Natl. Acad. Sci. USA, 88, 2166-2170.
26. Nishikimi, T., Miyata, A., Horio, T., Yoshihara, F., Nagaya, N., Takishita, S., Yutani, C., Matsuo, H., Matsuoka, H. & Kangawa, K. (2000) Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart. Am. J. Physiol. Heart Circ. Phystol., 279, H3031-H3039.
27. Overton, J.M., Davis, Gorman, G. & Fisher, L.A. (1990) Central nervous effects of CRF and angiotensin II on cardiac output in conscious rats. J. Appl. Physiol., 69, 788-791.
28. Overton, J.M. & Fisher, L.A. (1991) Differentiated hemodynamic responses to central versus peripheral administration of corticotropin-releasing factor in conscious rats. J. Auton. Nerv. Syst., 35, 43-51.
29. Parkes, D., Vaughan, J., Vale, W & May, C. (1997) Cardiac inotropic actions of urocortin in conscious sheep. Am. J. Physiol., 272, H2115-H2122.
30. Potter, E., Sutton, S., Donaldson, C., Chen, R., Perin, M., Lewis, K., Sawchenko, P.E., & Vale, W. (1994) Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc. Natl. Acad. Sci. USA, 91, 8777-8781.
31. + channel opener BRL 34915 in vascular smooth muscle. Br. J. Pharmacol., 93, 204p.
32. Rademaker, M.T. (2004) Urocortin: Cardiovascular Actions and Therapeutic Implications. Lett. Drug Des. Discovery, 1, 168-172.
33. Sanz, E., Monge, L., Fernandez, N., Martinez, M.A., Martinez-Leon, J.B., Dieguez, G. & Garcia-Villalon, A.L. (2002) Relaxation by urocortin of human saphenous veins. Br. J. Pharmacol., 136, 90-94.
34. Sanz, E., Fernandez, N., Monge, L., Climent, B., Dieguez, G. & Garcia-Villalon, A.L. (2003) Relaxation by urocortin of rat renal arteries: effects of diabetes in males and females. Cardiovasc. Res., 58, 706-711.
35. Schilling, L., Kanzler, C., Schmiedek, P. & Ehrenreich, H. (1998) Characterization of the relaxant action of urocortin, a new peptide related to corticotropin-releasing factor in the rat isolated basilar artery. Br. J. Pharmacol., 125, 1164-1171.
36. Terui, K., Higashiyama, A., Horiba, N., Furukawa, K.I., Motomura, S. & Suda, T. (2001) Coronary vasodilatation and positive inotropism by urocortin in the isolated rat heart. J. Endocrinol., 169, 177-183.
37. Tomioka, H., Hattori, Y., Fukao, M., Sato, A., Liu, M., Sakuma, I., Kitabatake, A. & Kano, M. (1999) Relaxation in different-sized rat blood vessels mediated by endothelium-derived hyperpolarizing factor: importance of processes mediating precontractions. J. Vasc. Res., 36, 311-320.
38. Tseng, C.M.L., Tabrizi-Fard, M.A. & Fung, H.L. (2000) Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation. J. Pharmacol. Exp. Ther., 292, 737-742.
39. Vaughan, J., Donaldson, C., Bittencourt, J., Perin, M.H., Lewis, K., Sutton, S., Chan, R., Turnbull, A., Lovejoy, D., Rivier, J., Sawchenko, P. & Vale, W. (1995) Urocortin a mammalian neuropeptide related to fish urotensin 1 and corticotropin-releasing factor. Nature, 378, 287-292.
40. Zhao, L., Donaldson, C.J., Smith, G. Vale, W.W. (1998) The structures of the Mouse and human urocortin genes (ucn and UCN) Genomics, 50, 23-33.